{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:54:51Z","timestamp":1791165291187,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,5,22]],"date-time":"2008-05-22T00:00:00Z","timestamp":1211414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s00296-008-0593-9","type":"journal-article","created":{"date-parts":[[2008,5,21]],"date-time":"2008-05-21T07:19:46Z","timestamp":1211354386000},"page":"1117-1121","source":"Crossref","is-referenced-by-count":53,"title":["The relationship between serum trace element levels and clinical parameters in patients with fibromyalgia"],"prefix":"10.1007","volume":"28","author":[{"given":"Omer Faruk","family":"Sendur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engin","family":"Tastaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cevval","family":"Ulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,22]]},"reference":[{"key":"593_CR1","first-page":"511","volume-title":"Textbook of rheumatology","author":"RM Bennett","year":"1997","unstructured":"Bennett RM (1997) The fibromyalgia syndrome. In: Kelley WN, Haris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology. WB Saunders Company, Philadelphia, pp 511\u2013519"},{"key":"593_CR2","first-page":"6","volume":"75","author":"P Mease","year":"2005","unstructured":"Mease P (2005) Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 75:6\u201321","journal-title":"J Rheumatol Suppl"},{"key":"593_CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/138161206775193271","volume":"12","author":"S Ozgocmen","year":"2006","unstructured":"Ozgocmen S (2006) New strategies in evaluation of therapeutic efficacy in fibromyalgia syndrome. Curr Pharm Des 12:67\u201371","journal-title":"Curr Pharm Des"},{"key":"593_CR4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0891-5849(90)90076-U","volume":"8","author":"TM Bray","year":"1990","unstructured":"Bray TM, Bettger WJ (1990) The physiological role of zinc as an antioxidant. Free Radic Biol Med 8:281\u2013291","journal-title":"Free Radic Biol Med"},{"key":"593_CR5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/cc5109","volume":"10","author":"X Forceville","year":"2006","unstructured":"Forceville X (2006) Seleno-enzymes and seleno-compounds: the two faces of selenium. Crit Care 10:180","journal-title":"Crit Care"},{"key":"593_CR6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1615\/JEnvironPatholToxicolOncol.v25.i3.40","volume":"25","author":"S Frassinetti","year":"2006","unstructured":"Frassinetti S, Bronzetti G, Caltavuturo L, Cini M, Croce CD (2006) The role of zinc in life: a review. J Environ Pathol Toxicol Oncol 25:597\u2013610","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"593_CR7","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/jn\/130.5.1447S","volume":"130","author":"SR Powell","year":"2000","unstructured":"Powell SR (2000) The antioxidant properties of zinc. J Nutr 130:1447\u20131454","journal-title":"J Nutr"},{"key":"593_CR8","first-page":"165","volume":"4","author":"TJ Romano","year":"1994","unstructured":"Romano TJ, Stiller JW (1994) Magnesium deficiency in fibromyalgia syndrome. J Nutr Med 4:165\u2013167","journal-title":"J Nutr Med"},{"key":"593_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","volume":"38","author":"F Wolfe","year":"1995","unstructured":"Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19\u201328","journal-title":"Arthritis Rheum"},{"key":"593_CR10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160\u2013172","journal-title":"Arthritis Rheum"},{"key":"593_CR11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3959(83)90126-4","volume":"17","author":"DD Price","year":"1983","unstructured":"Price DD, McGrath PA, Rafii A, Buckingham B (1983) The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 17:45\u201356","journal-title":"Pain"},{"key":"593_CR12","first-page":"728","volume":"18","author":"CS Burckhardt","year":"1991","unstructured":"Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728\u2013733","journal-title":"J Rheumatol"},{"key":"593_CR13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s002960000077","volume":"20","author":"S Sarmer","year":"2000","unstructured":"Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9\u201312","journal-title":"Rheumatol Int"},{"key":"593_CR14","first-page":"451","volume":"69","author":"MB Yunus","year":"1988","unstructured":"Yunus MB, Raman KIUP, Raman KK (1988) Primary fibromyalgia syndrome and myofacial pain syndrome: clinical features and muscle pathology. Arch Phys Med Rehabil 69:451\u2013454","journal-title":"Arch Phys Med Rehabil"},{"key":"593_CR15","first-page":"49","volume":"3","author":"GE Abraham","year":"1992","unstructured":"Abraham GE, Flechas JD (1992) Management of fibromyalgia: rationale for the use of magnesium and malic acid. J Nutr Med 3:49\u201359","journal-title":"J Nutr Med"},{"issue":"31","key":"593_CR16","first-page":"154","volume":"94","author":"E Prescott","year":"1992","unstructured":"Prescott E, Norregard J, Pedersen LR, Danneskiold SB, B\u00fclow P (1992) Red blood cell magnesium and fibromyalgia. Scand J Rheumatol 94(31):154","journal-title":"Scand J Rheumatol"},{"key":"593_CR17","first-page":"285","volume":"7","author":"J Eisinger","year":"1994","unstructured":"Eisinger J, Plantamura A, Marie PA, Ayavou T (1994) Selenium and magnesium status in fibromyalgia. Magnes Res 7:285\u2013288","journal-title":"Magnes Res"},{"key":"593_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J094v05n04_02","volume":"5","author":"J Eisinger","year":"1998","unstructured":"Eisinger J (1998) Reactive oxygen species, antioxidant status and fibromyalgia. J Musculoskeletal Pain 5:5\u201315","journal-title":"J Musculoskeletal Pain"},{"issue":"1","key":"593_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-4933-4-5","volume":"4","author":"E Mocchegiani","year":"2007","unstructured":"Mocchegiani E (2007) Zinc and ageing: third zinc age conference. Immun Ageing 4(1):5","journal-title":"Immun Ageing"},{"issue":"3","key":"593_CR20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1179\/135100006X116628","volume":"11","author":"O Altindag","year":"2006","unstructured":"Altindag O, Celik H (2006) Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep 11(3):131\u2013135","journal-title":"Redox Rep"},{"key":"593_CR21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00296-005-0078-z","volume":"26","author":"S Ozgocmen","year":"2006","unstructured":"Ozgocmen S, Ozyurt H, Sogut S, Akyol O (2006) Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide. Rheumatol Int 26:585\u2013559","journal-title":"Rheumatol Int"},{"issue":"2\/3","key":"593_CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jad.2005.11.002","volume":"90","author":"M Maes","year":"2006","unstructured":"Maes M, Mihaylova I, De Ruyter M (2006) Lower serum zinc in chronic fatigue syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. J Affect Disord 90(2\/3):141\u2013147","journal-title":"J Affect Disord"},{"key":"593_CR23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1192\/bjp.156.4.534","volume":"156","author":"I Hickie","year":"1990","unstructured":"Hickie I, Lloyd A, Wakefield D, Parker G (1990) The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychol 156:534\u2013540","journal-title":"Br J Psychol"},{"issue":"4","key":"593_CR24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10067-006-0433-9","volume":"26","author":"M Meeus","year":"2007","unstructured":"Meeus M, Nijs J (2007) Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol 26(4):465\u2013473","journal-title":"Clin Rheumatol"},{"issue":"2","key":"593_CR25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1079\/BJN19790107","volume":"42","author":"HM Rea","year":"1979","unstructured":"Rea HM, Thomson CD, Campbell DR, Robinson MF (1979) Relation between erythrocyte selenium concentrations and glutathione peroxidase (EC 1.11.1.9) activities of New Zealand residents and visitors to New Zealand. Br J Nutr 42(2):201\u2013208","journal-title":"Br J Nutr"},{"key":"593_CR26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0378-4274(98)00066-6","volume":"96\u201397","author":"P Reinhard","year":"1998","unstructured":"Reinhard P, Schweinsberg F, Wernet D, Kotter I (1998) Selenium status in fibromyalgia. Toxicol Lett 96\u201397:177\u2013180","journal-title":"Toxicol Lett"},{"key":"593_CR27","volume-title":"Pharmacology of micronutrients","author":"NW Flodin","year":"1988","unstructured":"Flodin NW (1988) Pharmacology of micronutrients. Alan R. Liss, New York"},{"key":"593_CR28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.1780260701","volume":"26","author":"SM Campbell","year":"1983","unstructured":"Campbell SM, Clark S, Tindall EA, Forehand ME, Bennett RM (1983) Clinical characteristics of fibrositis. I. A \u201cblinded\u201d, controlled study of symptoms and tender points. Arthritis Rheum 26:817\u2013824","journal-title":"Arthritis Rheum"},{"key":"593_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/07853899708998739","volume":"29","author":"DJ Wallace","year":"1997","unstructured":"Wallace DJ (1997) The fibromyalgia syndrome. Ann Med 29:9\u201321","journal-title":"Ann Med"},{"key":"593_CR30","first-page":"1577","volume":"26","author":"KP White","year":"1999","unstructured":"White KP, Speechley M, Harth M, Ostbye T (1999) The London fibromyalgia epidemiology study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 26:1577\u20131585","journal-title":"J Rheumatol"},{"issue":"3","key":"593_CR31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/07315724.2000.10718934","volume":"19","author":"BM Keenoy","year":"2000","unstructured":"Keenoy BM, Moorkens G, Vertommen J, Noe M, Neve J, De Leeuw I (2000) Magnesium status and parameters of the oxidant\u2013antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium. J Am Coll Nutr 19(3):374\u2013382","journal-title":"J Am Coll Nutr"},{"key":"593_CR32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0140-6736(92)90455-C","volume":"340","author":"JE Clague","year":"1992","unstructured":"Clague JE, Edwards RHT, Jackson MJ (1992) Intravenous magnesium loading in chronic fatigue syndrome. Lancet 340:124\u2013125","journal-title":"Lancet"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-008-0593-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-008-0593-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-008-0593-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:16:11Z","timestamp":1559042171000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-008-0593-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,22]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1007\/s00296-008-0593-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,22]]}}}